IBL Healthcare invests in KNISS Laboratories
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
KNISS has established a solid foundation of trust in the customers' minds, delivering high quality Products uncompromisingly.
Rs. 64000 crores are being invested across the 750 districts of India, to create a more resilient healthcare system in the country
With India supplying around 60% of the world's vaccine needs and 20-22% of generic exports, the country is dedicated to providing affordable, high-quality drugs and contribute to global accessibility
The campaign seeks to raise awareness about hypertension while emphasising the significance of managing blood pressure for a healthier lifestyle
Global Initiative on Digital Health launched at the G2O Health Minister’s Meeting
Need to harmonize traditional and modern medicine to combat alarming health problems
Aurobindo's product is already filed with the Drugs Controller General of India (DCGI) and is expected to be approved soon
CrisprBits has developed a platform to build rapid, precise, and affordable POC tests for a wide range of disease and health conditions
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
The National Dental Commission Act 2023, will introduce a groundbreaking regulatory framework by establishing the National Dental Commission
Subscribe To Our Newsletter & Stay Updated